RXRX logo

RXRX Long Term Liabilities

Annual Total Long Term Liabilities

$226.34 M
+$129.25 M+133.12%

December 31, 2024


Summary


Performance

RXRX Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXRXbalance sheetmetrics:

Quarterly Long Term Liabilities

$226.34 M
+$133.29 M+143.24%

December 31, 2024


Summary


Performance

RXRX Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXRXbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

RXRX Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+133.1%+143.2%
3 y3 years+990.9%+143.2%
5 y5 years+3.4%+143.2%

RXRX Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+990.9%at high+990.9%
5 y5-year-53.0%+990.9%-53.0%+1261.0%
alltimeall time-53.0%+990.9%-53.0%+1261.0%

Recursion Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Dec 2024
$226.34 M(+133.1%)
$226.34 M(+143.2%)
Sep 2024
-
$93.05 M(-11.7%)
Jun 2024
-
$105.33 M(+27.2%)
Mar 2024
-
$82.78 M(-14.7%)
Dec 2023
$97.09 M(-15.7%)
$97.09 M(-1.7%)
Sep 2023
-
$98.74 M(+17.9%)
Jun 2023
-
$83.78 M(-20.2%)
Mar 2023
-
$105.04 M(-8.8%)
Dec 2022
$115.22 M
$115.22 M(-18.0%)
DateAnnualQuarterly
Sep 2022
-
$140.46 M(+1.6%)
Jun 2022
-
$138.28 M(-10.8%)
Mar 2022
-
$155.05 M(+647.3%)
Dec 2021
$20.75 M(-95.7%)
$20.75 M(+24.8%)
Sep 2021
-
$16.63 M(-36.9%)
Jun 2021
-
$26.34 M(-94.5%)
Mar 2021
-
$478.12 M(-0.8%)
Dec 2020
$481.77 M(+120.0%)
-
Dec 2020
-
$481.77 M
Dec 2019
$219.01 M
-

FAQ

  • What is Recursion Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Recursion Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Recursion Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of RXRX is $226.34 M

What is the all time high annual total long term liabilities for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high annual total long term liabilities is $481.77 M

What is Recursion Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, RXRX annual total long term liabilities has changed by +$129.25 M (+133.12%)

What is Recursion Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of RXRX is $226.34 M

What is the all time high quarterly long term liabilities for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high quarterly total long term liabilities is $481.77 M

What is Recursion Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, RXRX quarterly total long term liabilities has changed by +$133.29 M (+143.24%)